BeyondSpring (BYSI) vs Context Therapeutics (CNTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BeyondSpring (BYSI) has outperformed Context Therapeutics (CNTX) over the past year, losing 64.1% versus a loss of 72.3%. Context Therapeutics is the larger company by market cap ($29.0 million vs $25.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BYSI | CNTX |
|---|---|---|
| Share price | $0.6276 | $0.3158 |
| Market cap | $25.81M | $29.02M |
| 1-day change | -2.70% | +1.02% |
| YTD return | -60.46% | -78.73% |
| 1-year return | -64.09% | -72.34% |
| 5-year return | -96.11% | — |
| EPS (TTM) | $-0.18 | $-0.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.44 | $3.62 |
| 52-week low | $0.566 | $0.297 |
| Distance from 52-week high | -74.28% | -91.28% |
| Average volume | 855.49K | 1.83M |
| Shares outstanding | 41.12M | 91.88M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BYSI vs CNTX FAQ
Which is bigger, BeyondSpring or Context Therapeutics?
Context Therapeutics (CNTX) is larger, with a market capitalization of $29.02M compared with $25.81M for BeyondSpring (BYSI).
Which stock has performed better over the past year, BYSI or CNTX?
BYSI returned -64.09% over the past 12 months, compared with -72.34% for CNTX (price return, excluding dividends). Past performance does not predict future results.
Are BeyondSpring and Context Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.